Oxidative biotransformation of stemofoline alkaloids

Artif Cells Nanomed Biotechnol. 2021 Dec;49(1):166-172. doi: 10.1080/21691401.2021.1883044.

Abstract

Biotransformations of stemofoline (1a), (2'S)-hydroxystemofoline (2a), (11Z)-1',2'-didehydrostemofoline (3a) and stemocurtisine (4) were studied through fermentation with Cunninghamella elegans TISTR 3370. Three new stemofoline derivatives; 6 R-hydroxystemofoline (1b), (2'S, 6 R)-dihydroxystemofoline (2b) and (11Z,6R)-1',2'-didehydro-6-hydroxystemofoline (3b), together with the known compound 1',2'-didehydrostemofoline-N-oxide (3c), were produced by C-hydroxylation and N-oxidation reactions. Stemocurtisine was not biotransformed under these conditions. The transformed product 1b was four times more potent (IC50 = 11.01 ± 1.49 µM) than its precursor 1a (IC50 = 45.1 ± 5.46 µM) as an inhibitor against acetylcholinesterase.

Keywords: Biotransformation; Cunninghamella elegans; Stemona alkaloids; stemofoline.

MeSH terms

  • Alkaloids / chemistry*
  • Alkaloids / metabolism*
  • Biotransformation
  • Cunninghamella / metabolism
  • Fermentation
  • Heterocyclic Compounds, 4 or More Rings / chemistry*
  • Oxidation-Reduction

Substances

  • Alkaloids
  • Heterocyclic Compounds, 4 or More Rings
  • stemofoline

Supplementary concepts

  • Cunninghamella elegans